Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) may be superior to C-reactive protein (CRP) for predicting the occurrence of differentiated thyroid cancer
Objectives. NLR (neutrophil-lymphocyte ratio) and PLR (platelet-lymphocyte ratio) are prognostic markers of differentiated thyroid cancers. In our study, we evaluated NLR, PLR and C-reactive protein (CRP) for predicting the occurence of differentiated thyroid cancer. This is the first study that com...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Sciendo
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b38c36bf5eda495b8056b731cd737301 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:b38c36bf5eda495b8056b731cd737301 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:b38c36bf5eda495b8056b731cd7373012021-12-02T16:33:01ZNeutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) may be superior to C-reactive protein (CRP) for predicting the occurrence of differentiated thyroid cancer1336-032910.1515/enr-2017-0013https://doaj.org/article/b38c36bf5eda495b8056b731cd7373012017-07-01T00:00:00Zhttps://doi.org/10.1515/enr-2017-0013https://doaj.org/toc/1336-0329Objectives. NLR (neutrophil-lymphocyte ratio) and PLR (platelet-lymphocyte ratio) are prognostic markers of differentiated thyroid cancers. In our study, we evaluated NLR, PLR and C-reactive protein (CRP) for predicting the occurence of differentiated thyroid cancer. This is the first study that compares NLR and PLR to C-reactive protein indifferantiated thyroid cancer not only papillary cancer but also folliculer cancer.Ozmen STimur OCalik IAltinkaynak KSimsek EGozcu HArslan ACarlioglu ASciendoarticleneutrophil-lymphocyte ratioplatelet-lymphocyte ratioc-reactive proteindifferentiated thyroid cancerDiseases of the endocrine glands. Clinical endocrinologyRC648-665ENEndocrine Regulations, Vol 51, Iss 3, Pp 131-136 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
neutrophil-lymphocyte ratio platelet-lymphocyte ratio c-reactive protein differentiated thyroid cancer Diseases of the endocrine glands. Clinical endocrinology RC648-665 |
spellingShingle |
neutrophil-lymphocyte ratio platelet-lymphocyte ratio c-reactive protein differentiated thyroid cancer Diseases of the endocrine glands. Clinical endocrinology RC648-665 Ozmen S Timur O Calik I Altinkaynak K Simsek E Gozcu H Arslan A Carlioglu A Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) may be superior to C-reactive protein (CRP) for predicting the occurrence of differentiated thyroid cancer |
description |
Objectives. NLR (neutrophil-lymphocyte ratio) and PLR (platelet-lymphocyte ratio) are prognostic markers of differentiated thyroid cancers. In our study, we evaluated NLR, PLR and C-reactive protein (CRP) for predicting the occurence of differentiated thyroid cancer. This is the first study that compares NLR and PLR to C-reactive protein indifferantiated thyroid cancer not only papillary cancer but also folliculer cancer. |
format |
article |
author |
Ozmen S Timur O Calik I Altinkaynak K Simsek E Gozcu H Arslan A Carlioglu A |
author_facet |
Ozmen S Timur O Calik I Altinkaynak K Simsek E Gozcu H Arslan A Carlioglu A |
author_sort |
Ozmen S |
title |
Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) may be superior to C-reactive protein (CRP) for predicting the occurrence of differentiated thyroid cancer |
title_short |
Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) may be superior to C-reactive protein (CRP) for predicting the occurrence of differentiated thyroid cancer |
title_full |
Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) may be superior to C-reactive protein (CRP) for predicting the occurrence of differentiated thyroid cancer |
title_fullStr |
Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) may be superior to C-reactive protein (CRP) for predicting the occurrence of differentiated thyroid cancer |
title_full_unstemmed |
Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) may be superior to C-reactive protein (CRP) for predicting the occurrence of differentiated thyroid cancer |
title_sort |
neutrophil-lymphocyte ratio (nlr) and platelet-lymphocyte ratio (plr) may be superior to c-reactive protein (crp) for predicting the occurrence of differentiated thyroid cancer |
publisher |
Sciendo |
publishDate |
2017 |
url |
https://doaj.org/article/b38c36bf5eda495b8056b731cd737301 |
work_keys_str_mv |
AT ozmens neutrophillymphocyterationlrandplateletlymphocyteratioplrmaybesuperiortocreactiveproteincrpforpredictingtheoccurrenceofdifferentiatedthyroidcancer AT timuro neutrophillymphocyterationlrandplateletlymphocyteratioplrmaybesuperiortocreactiveproteincrpforpredictingtheoccurrenceofdifferentiatedthyroidcancer AT caliki neutrophillymphocyterationlrandplateletlymphocyteratioplrmaybesuperiortocreactiveproteincrpforpredictingtheoccurrenceofdifferentiatedthyroidcancer AT altinkaynakk neutrophillymphocyterationlrandplateletlymphocyteratioplrmaybesuperiortocreactiveproteincrpforpredictingtheoccurrenceofdifferentiatedthyroidcancer AT simseke neutrophillymphocyterationlrandplateletlymphocyteratioplrmaybesuperiortocreactiveproteincrpforpredictingtheoccurrenceofdifferentiatedthyroidcancer AT gozcuh neutrophillymphocyterationlrandplateletlymphocyteratioplrmaybesuperiortocreactiveproteincrpforpredictingtheoccurrenceofdifferentiatedthyroidcancer AT arslana neutrophillymphocyterationlrandplateletlymphocyteratioplrmaybesuperiortocreactiveproteincrpforpredictingtheoccurrenceofdifferentiatedthyroidcancer AT carlioglua neutrophillymphocyterationlrandplateletlymphocyteratioplrmaybesuperiortocreactiveproteincrpforpredictingtheoccurrenceofdifferentiatedthyroidcancer |
_version_ |
1718383775494176768 |